Alvotech (ALVO) Total Liabilities (2020 - 2026)
Alvotech's (ALVO) quarterly Total Liabilities came in at $1.7 billion in Q1 2026, up 4.24% YoY from $1.6 billion in Q1 2025, and down 3.84% on a QoQ basis from $1.8 billion in Q4 2025.
Alvotech (ALVO) Total Liabilities (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Total Liabilities data on file, last reported at $1.7 billion in Q1 2026.
- Quarterly Total Liabilities rose 4.24% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 4.24% YoY) and the FY2025 annual result came in at $1.8 billion, up 8.41% from the prior year.
- Total Liabilities fell to $1.7 billion in Q1 2026, from $1.8 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.9 billion in Q4 2023 to a low of $1.1 billion in Q2 2022.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 89.87% — and 2024, when it dropped 13.2%.
- Tracing ALVO's Total Liabilities over 5 years: stood at $1.4 billion in 2022, then soared by 35.16% to $1.9 billion in 2023, then retreated by 13.2% to $1.6 billion in 2024, then rose by 8.41% to $1.8 billion in 2025, then declined by 3.84% to $1.7 billion in 2026.
- The last three Total Liabilities figures came in at $1.7 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.63 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Jun 30, 2023 | 1.39 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Dec 31, 2021 | 733.59 Mn |
| Dec 31, 2020 | 534.70 Mn |